Literature DB >> 35923512

Feasibility of Sentinel Lymph Node Sampling in Early-Stage Carcinoma Endometrium: Single-Institution Experience.

Aswathy G Nath1, S Suchetha1, V M Pradeep2, P Rema1, J Sivaranjith3, Jagathnath Krishna4, Rari P Mony5.   

Abstract

Introduction: Accurate surgical staging is an essential component in the management of carcinoma endometrium to assess the stage of disease and to tailor adjuvant treatment. Sentinel node technique was introduced as an alternative for extensive lymphadenectomy in early stages to avoid complications associated with lymphadenectomy. Aims and
Objectives: To assess the detection rate and diagnostic accuracy of SLN mapping in patients with early-stage carcinoma endometrium. Materials and
Methods: Prospective validation study involving 30 patients diagnosed to have early-stage carcinoma endometrium. Sentinel nodes were detected by combined methods of radio colloid dye and isosulphan blue dye injection.
Results: Sentinel lymph node was detected in 19 patients (63.4%). 11 patients had no sentinel nodes. Total number of sentinel nodes isolated was 68 with a mean of 2.26 per patient (range 0-4). Ten (33.33%) patients had single sentinel node location, while 9 (30%) had more than 1 sentinel lymph nodes. Twelve patients had bilateral sentinel nodes, and the most frequent location of sentinel node was obturator, 19 (63.3%) especially on right hemi-pelvis. One patient had a hot para-aortic node, while none had blue para-aortic sentinel node. Average number of lymph nodes obtained by lymphadenectomy was 13 per patient (range 7-22). All patients with sentinel node had negative frozen report as well as in histopathology. Two patients in whom no sentinel nodes were detected by either techniques had metastatic nodes in histopathology report.
Conclusion: Detection rate was maximum with radiocolloid dye, and it is better to utilize the technique for less graded tumours and endometrioid variants. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Carcinoma endometrium; Detection rate; Sentinel nodes

Year:  2021        PMID: 35923512      PMCID: PMC9339440          DOI: 10.1007/s13224-021-01530-w

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  15 in total

1.  Credentialing for breast lymphatic mapping: how many cases are enough?

Authors:  H S Cody; A D Hill; K N Tran; M F Brennan; P I Borgen
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

2.  A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.

Authors:  Emma C Rossi; Lynn D Kowalski; Jennifer Scalici; Leigh Cantrell; Kevin Schuler; Rabbie K Hanna; Michael Method; Melissa Ade; Anastasia Ivanova; John F Boggess
Journal:  Lancet Oncol       Date:  2017-02-01       Impact factor: 41.316

3.  ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?

Authors:  W T Creasman; David E Mutch; Thomas J Herzog
Journal:  Gynecol Oncol       Date:  2009-11-07       Impact factor: 5.482

Review 4.  99mTc SPECT/CT Versus Planar Lymphoscintigraphy for Preoperative Sentinel Lymph Node Detection in Cervical Cancer: A Systematic Review and Metaanalysis.

Authors:  Jacob P Hoogendam; Wouter B Veldhuis; Monique G G Hobbelink; René H M Verheijen; Maurice A A J van den Bosch; Ronald P Zweemer
Journal:  J Nucl Med       Date:  2015-04-09       Impact factor: 10.057

5.  Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial.

Authors:  Emma J Crosbie; Chris Roberts; Wendi Qian; Ann Marie Swart; Henry C Kitchener; Andrew G Renehan
Journal:  Eur J Cancer       Date:  2011-11-17       Impact factor: 9.162

6.  Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.

Authors:  Marco Maccauro; Giovanni Lucignani; Gianluca Aliberti; Carlo Villano; Maria Rita Castellani; Eugenio Solima; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-30       Impact factor: 9.236

7.  Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?

Authors:  Nadeem R Abu-Rustum; Fady Khoury-Collado; Neeta Pandit-Taskar; Robert A Soslow; Fanny Dao; Yukio Sonoda; Douglas A Levine; Carol L Brown; Dennis S Chi; Richard R Barakat; Mary L Gemignani
Journal:  Gynecol Oncol       Date:  2009-02-20       Impact factor: 5.482

8.  Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?

Authors:  Fady Khoury-Collado; Gretchen E Glaser; Oliver Zivanovic; Yukio Sonoda; Douglas A Levine; Dennis S Chi; Mary L Gemignani; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2009-09-19       Impact factor: 5.482

9.  The outcomes of 27,063 women with unstaged endometrioid uterine cancer.

Authors:  John K Chan; Huahsi Wu; Michael K Cheung; Jacob Y Shin; Kathryn Osann; Daniel S Kapp
Journal:  Gynecol Oncol       Date:  2007-08       Impact factor: 5.482

10.  Sentinel node mapping with isosulfan blue dye in endometrial cancer.

Authors:  Lilian T Gien; Janice S Kwon; Mark S Carey
Journal:  J Obstet Gynaecol Can       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.